Quratis Inc. (KOSDAQ: A348080)
Health Care · Biotechnology · KR
₩3,310.00
-11.50% today · -62.1% 1Y
Quratis Inc. (KOSDAQ: A348080) operates in the Biotechnology industry within the Health Care sector. The company is valued at $29.12M.
Over the last twelve months the share price has lost 62.1%, trading between 1.76K and 13.37K.
Tweenvest scores Quratis Inc. across four factors: quality 40/100, value 43/100, growth 100/100. Its strongest factor is growth.
A348080 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $29.12M
- Revenue (TTM)
- $707.73K
- P/E
- —
- EPS
- -254.56
- Dividend yield
- —
- Beta (5Y)
- -0.33
- 52-week high
- ₩13,365.00
- 52-week low
- ₩1,765.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.73M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nicox S.A.ENXTPA: ALCOX | $29.74M | €0.30 | -2.91% |
| Cleo Diagnostics LtdASX: COV | $29.57M | AU$0.31 | -1.59% |
| Parataxis Korea, Inc.KOSDAQ: A288330 | $29.36M | ₩— | — |
| Medicenna Therapeutics Corp.TSX: MDNA | $29.36M | CA$0.45 | +3.45% |
| Microbix Biosystems Inc.TSX: MBX | $29.05M | CA$0.30 | -3.23% |
| TransCode Therapeutics, Inc.NasdaqCM: RNAZ | $28.78M | $1.70 | -8.60% |
| Amplia Therapeutics LimitedASX: ATX | $28.57M | AU$0.08 | -23.81% |
| NextCure, Inc.NasdaqGS: NXTC | $28.56M | $6.24 | -13.09% |
Figures last refreshed Oct 18, 2026.